Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies98
  • 7D-0.3%
  • 3M-0.9%
  • 1Y9.1%
  • YTDn/a

The Healthcare Services industry has stayed flat over the last week. As for the the longer term, the industry is up 9.1% over the past 12 months. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025US$302.1bUS$757.3bUS$8.5b34x35.4x0.4x
Wed, 15 Oct 2025US$301.6bUS$739.4bUS$11.3b25.1x26.6x0.4x
Fri, 12 Sep 2025US$298.9bUS$740.0bUS$11.4b24.6x26.3x0.4x
Sun, 10 Aug 2025US$276.6bUS$742.7bUS$11.4b21.8x24.2x0.4x
Tue, 08 Jul 2025US$293.1bUS$727.3bUS$12.5b24.7x23.5x0.4x
Thu, 05 Jun 2025US$286.5bUS$727.1bUS$12.3b25.7x23.3x0.4x
Sat, 03 May 2025US$292.5bUS$717.2bUS$10.5b27.8x27.8x0.4x
Mon, 31 Mar 2025US$286.2bUS$710.5bUS$9.4b29.4x30.4x0.4x
Wed, 26 Feb 2025US$285.1bUS$708.6bUS$9.2b28x30.9x0.4x
Fri, 24 Jan 2025US$264.7bUS$686.7bUS$8.7b27x30.4x0.4x
Sun, 22 Dec 2024US$244.6bUS$686.8bUS$7.9b25.9x31x0.4x
Tue, 19 Nov 2024US$276.0bUS$689.2bUS$7.8b30.7x35.3x0.4x
Thu, 17 Oct 2024US$302.8bUS$667.7bUS$10.6b34.4x28.5x0.5x
Sat, 14 Sep 2024US$292.2bUS$667.5bUS$10.6b33.8x27.7x0.4x
Mon, 12 Aug 2024US$280.6bUS$667.5bUS$10.5b34.4x26.7x0.4x
Wed, 10 Jul 2024US$270.6bUS$654.3bUS$10.2b29.1x26.5x0.4x
Fri, 07 Jun 2024US$281.4bUS$654.3bUS$10.2b28.8x27.6x0.4x
Sun, 05 May 2024US$277.9bUS$656.0bUS$9.3b30.4x29.8x0.4x
Tue, 02 Apr 2024US$319.7bUS$643.1bUS$11.8b31.9x27.1x0.5x
Thu, 29 Feb 2024US$307.8bUS$642.3bUS$13.1b34.6x23.6x0.5x
Sat, 27 Jan 2024US$307.3bUS$634.3bUS$13.6b35.1x22.6x0.5x
Mon, 25 Dec 2023US$320.9bUS$625.8bUS$13.8b34x23.3x0.5x
Wed, 22 Nov 2023US$296.3bUS$625.6bUS$13.7b32.7x21.6x0.5x
Fri, 20 Oct 2023US$310.8bUS$612.2bUS$8.8b28.9x35.4x0.5x
Sun, 17 Sep 2023US$307.4bUS$611.1bUS$8.8b26.1x34.8x0.5x
Tue, 15 Aug 2023US$322.4bUS$610.7bUS$8.7b31.2x37.2x0.5x
Thu, 13 Jul 2023US$308.7bUS$598.1bUS$10.4b26.9x29.6x0.5x
Sat, 10 Jun 2023US$310.8bUS$598.0bUS$10.1b28.1x30.7x0.5x
Mon, 08 May 2023US$306.0bUS$597.9bUS$10.0b25.1x30.6x0.5x
Wed, 05 Apr 2023US$313.8bUS$587.0bUS$11.0b22.8x28.4x0.5x
Fri, 03 Mar 2023US$329.9bUS$588.1bUS$11.6b22.7x28.4x0.6x
Sun, 29 Jan 2023US$349.9bUS$581.2bUS$10.8b22.6x32.5x0.6x
Tue, 27 Dec 2022US$358.7bUS$581.2bUS$10.8b21.4x33.1x0.6x
Thu, 24 Nov 2022US$364.7bUS$581.2bUS$10.9b20.6x33.6x0.6x
Price to Earnings Ratio

33.6x


Total Market Cap: US$364.7bTotal Earnings: US$10.9bTotal Revenue: US$581.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 28.5x202320242025
Current Industry PE
  • Investors are optimistic on the American Healthcare Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 35.4x which is higher than its 3-year average PE of 28.5x.
  • The industry is trading close to its 3-year average PS ratio of 0.46x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have declined 7.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Healthcare Services compare with similar industries?

US Market-0.39%
Healthcare3.77%
Healthcare Services-0.85%
Healthcare Services-0.34%
Healthcare Distributors0.069%
Managed Healthcare-0.61%
Healthcare Facilities-5.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CI Cigna GroupUS$269.664.5%
+US$3.1b		-16.4%PE11.7x
LH Labcorp HoldingsUS$266.892.2%
+US$477.5m		11.8%PE25.9x
CVS CVS HealthUS$77.810.3%
+US$342.7m		38.8%PE210.6x
DGX Quest DiagnosticsUS$186.951.4%
+US$293.7m		15.3%PE21.6x
DVA DaVitaUS$121.551.1%
+US$97.4m		-22.8%PE11.1x

Latest News

AVAH
US$8.45
Aveanna Healthcare Holdings
7D
-5.6%
1Y
48.5%
DGX
US$186.95
Quest Diagnostics
7D
1.4%
1Y
15.3%

DGX: Future Revenue Expansion And Partnerships Will Balance Near-Term Risks

Quest Diagnostics saw its analyst price target increase, with several firms now projecting new targets between $195 and $215 per share. Analysts cite strong quarterly results and ongoing positive momentum in core business trends.
LH
US$266.89
Labcorp Holdings
7D
2.2%
1Y
11.8%

LH: Share Repurchases And Expanded Alzheimer’s Testing Will Drive Future Upside

Narrative Update: Labcorp Holdings Analyst Price Target Adjustment Analysts have raised their price target for Labcorp Holdings by $1. This change reflects a marginally improved outlook based on updated fair value and company fundamentals.
RDNT
US$75.15
RadNet
7D
-7.1%
1Y
-5.0%

Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

Nov 14
Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts
HNGE
US$40.96
Hinge Health
7D
-7.5%
1Y
n/a
GH
US$94.37
Guardant Health
7D
-3.6%
1Y
225.9%
FLGT
US$29.10
Fulgent Genetics
7D
7.1%
1Y
74.1%

FLGT: Full-Year Guidance And Early Clinical Data Will Shape 2025 Outlook

Analysts have raised their price target for Fulgent Genetics from $25.33 to $27.00, citing slightly improved profit margin projections as well as updated market expectations. What's in the News Fulgent Genetics raised its earnings guidance for the full year 2025, expecting revenue of approximately $325 million and improving its EPS guidance to a GAAP loss of approximately $1.70 per share.
MD
US$23.15
Pediatrix Medical Group
7D
2.6%
1Y
60.0%

Pediatrix Medical Group's (NYSE:MD) Earnings Seem To Be Promising

Nov 10
Pediatrix Medical Group's (NYSE:MD) Earnings Seem To Be Promising
HIMS
US$36.98
Hims & Hers Health
7D
-9.9%
1Y
76.2%
CVS
US$77.81
CVS Health
7D
0.3%
1Y
38.8%

CVS: Earnings Momentum Will Drive Performance as Regulatory Shifts Unfold

Analysts have raised their fair value estimate for CVS Health to $91.52 from $86.20. This adjustment is due to improved earnings visibility and continued momentum following solid quarterly results.
BLLN
US$90.00
BillionToOne
7D
-12.0%
1Y
n/a
WGS
US$128.06
GeneDx Holdings
7D
-10.2%
1Y
80.1%

Shareholders Will Be Pleased With The Quality of GeneDx Holdings' (NASDAQ:WGS) Earnings

Nov 06
Shareholders Will Be Pleased With The Quality of GeneDx Holdings' (NASDAQ:WGS) Earnings
CI
US$269.66
Cigna Group
7D
4.5%
1Y
-16.4%
BTSG
US$32.00
BrightSpring Health Services
7D
-4.7%
1Y
71.3%

BTSG: Momentum Will Accelerate On Increased Efficiency And Operational Discipline

Analysts have raised their price target for BrightSpring Health Services from $32.96 to $38.25, citing stronger expected revenue growth and improved profit margins as key factors behind the revision. Analyst Commentary Recent updates from the Street point to shifts in sentiment surrounding BrightSpring Health Services.
OPCH
US$28.41
Option Care Health
7D
0.8%
1Y
30.7%
DVA
US$121.55
DaVita
7D
1.1%
1Y
-22.8%